HIMS
Overvalued by 116.5% based on the discounted cash flow analysis.
Market cap | $9.22 Billion |
---|---|
Enterprise Value | $9.24 Billion |
Dividend Yield | $- (-) |
Earnings per Share | $0.58 |
Beta | 2.09 |
Outstanding Shares | 224,373,375 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 49.08 |
---|---|
PEG | 22.34 |
Price to Sales | 6.01 |
Price to Book Ratio | 24.06 |
Enterprise Value to Revenue | 4.59 |
Enterprise Value to EBIT | 76.24 |
Enterprise Value to Net Income | 47 |
Total Debt to Enterprise | 0.12 |
Debt to Equity | 2.04 |
No data
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...